Target intelligence / Profile preview

THF-II riboswitch

Molecular classification
Riboswitch, Non-coding RNA element, Regulatory RNA, Other
01

Overview

The THF-II riboswitch is a conserved non-coding RNA structure found typically in the 5’ untranslated regions of bacterial mRNAs, where it regulates gene expression in response to binding tetrahydrofolic acid (THF) and closely related metabolites[1][3][4][5][6]. It adopts a simple, rod-like secondary and tertiary structure, with aptamer and expression platform regions largely overlapping, and recognizes THF via highly specific nucleotide-ligand contacts[1][3]. Ligand binding stabilizes specific local RNA conformations (notably in loop regions), promoting the formation of an anti-ribosome binding site (anti-RBS) stem that inhibits ribosome access, thereby shutting off translation[1][3][4]. While THF-II riboswitches have been proposed as potential novel antibiotic targets due to their bacterial specificity and essential regulatory role for folate-related metabolism, no drugs are currently approved to target them directly[4]. The THF-II riboswitch is distinct from the structurally related THF-I riboswitch, notably in its simpler architecture and more restricted ligand specificity[3][1].

Other names
Tetrahydrofolate-II riboswitchfolE RNA motif
02

Mechanism of action

Ligand binding (tetrahydrofolate or close analogs) induces a conformational switch that represses translation by preventing ribosome binding to the mRNA.

03

Biological functions

Gene expression regulationTranslation regulationLigand sensing (tetrahydrofolate)Other
04

Disease associations

InfectionAntibacterial targetOther

Beyond the preview

Go deeper on THF-II riboswitch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on THF-II riboswitch.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call